Table III.
Effect of baicalein on the expression of Bcl-2, Bax, PCNA and cyclin D1.
| Relative expression | ||||
|---|---|---|---|---|
| Baicalein 0 µM | Baicalein 40 µM | |||
| Protein | Median | P25-P75 | Median | P25-P75 |
| Bcl-2 | 1.000 | 1.000–1.000 | 0.661a | 0.629–0.762 |
| Bax | 1.000 | 1.000–1.000 | 1.061 | 0.993–1.141 |
| PCNa | 1.000 | 1.000–1.000 | 0.683a | 0.652–0.713 |
| Cyclin D1 | 1.000 | 1.000–1.000 | 0.698a | 0.659–0.701 |
Statistical comparisons were made using the Wilcoxon test.
a
P<0.05 vs. control group (0 µM baicalein). P25, 25th percentile; P75, 75th percentile; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; PCNA, proliferating cell nuclear antigen.